首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1345418

全球外周靜脈導管市場 - 2023-2030

Global Peripheral IV Catheters Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球外周靜脈導管市場規模達到52億美元，預計到2030年將達到91億美元，2023-2030年預測期間年複合成長率為7.4%。

外周靜脈導管 (PIVC) 是最常用的靜脈裝置，主要用於治療目的，例如給藥、輸液和血液製品。導管位置、通暢/閉塞、肢體對稱性、靜脈炎的任何證據（紅斑、不適、腫脹、疼痛等）、壓力損傷以及浸潤/外滲損傷的體徵均在外周靜脈導管評估中進行評估。

此外，全球外周靜脈導管市場受到慢性疾病患病率上升、技術進步、微創手術增加以及強勁醫療保健支出的推動，這些因素將在預測期內推動市場發展。

動力學

心血管疾病患病率上升

患有某些心血管疾病（例如心房顫動或深靜脈血栓形成）的患者可能需要抗凝治療以避免血栓。靜脈 (IV) 導管可以提供肝素等抗凝藥物，以維持健康的血流。心血管疾病發病率的上升是預測期內推動市場的重要促進因素。

例如，根據美國疾病控制與預防中心更新的 2023 年情況說明書，心臟病是美國男性、女性以及大多數種族和民族群體個人的主要原因。在美國，每 33 秒就有一人死於心血管疾病。

2021 年，美國約有 695,000 人死於心臟病，佔死亡人數的五分之一。 2018年至2019年，美國在心臟病方面的支出約為2399億美元。這涵蓋了醫療保健服務、藥物的費用以及因死亡而造成的生產力損失。

技術進步的崛起

技術進步的成長是預測期內推動市場的關鍵因素之一。例如，2023 年 4 月，全球醫療技術公司 BD 推出了 BD Prevue II 系統，這是一種先進的超聲設備，配有專用探頭，可實現最佳 IV 放置。

該系統通過即時針深度標記解決了 IV 通路未滿足的需求，並採用 BD Cue 針追蹤系統，提供針軌蹟的高品質超聲圖像。它與 BD Cue 針追蹤導管兼容。 BD Prevue II 系統旨在為臨床醫生提供最佳的靜脈注射放置位置，並且易於使用。

老年人口的增加

隨著人口老齡化，需要更多的醫療程序，例如靜脈治療。隨著人口老齡化，對外周靜脈導管提供藥物和液體的需求也在不斷成長。

老年人更容易出現心臟病。隨著全球老年人口的成長，與年齡相關的心臟問題患病率的增加預計將增加對起搏器的需求。

例如，根據《臨床心臟病學》發表的一篇文章，大約 60% 的 60 歲以上的美國人口患有高血壓，導致心臟病發作，從而導致對外周靜脈導管的需求增加。到2060年，65歲及以上的人口數量將達到美國總人口的25%，其中80歲以上的人口將達到200億。

針刺損傷的增加鼓勵採用外周靜脈導管

對於需要頻繁注射的患者來說，注射針的針刺傷是一個主要問題。處理、拆卸甚至丟棄針頭和注射器可能會導致針尖造成經皮傷口損傷。據美國醫學協會稱，針刺在醫療保健行業中很常見。據估計，美國每年發生 60 萬至 80 萬起針刺傷。

例如，2022 年 7 月，輸液治療領域的領導者貝朗醫療公司 (B. Braun Medical Inc) 宣布推出具有拋棄式血液控制功能的新型 Introcan Safety 2 IV 導管。 Introcan Safety 2 IV 導管是 B. Braun 的最新開發產品，可降低針刺傷害和接觸血液的風險，從而使臨床醫生的 IV 通路更加安全

與導管相關的風險和併發症

原位外周靜脈導管可能會出現併發症，儘管可以通過充分的無菌操作和設備評估來避免這些併發症。感染、靜脈炎、導管/液體/藥物的存在以及長期不適的患者的困難都是常見的後果。當液體或藥物輸送到周圍組織時，就會發生滲透/外滲；如果發生這種情況，請參閱外滲損傷處理護理指南。通過採用適當的無菌技術和評估可以避免這些問題。

Overview

Global Peripheral IV Catheters Market reached US$ 5.2 billion in 2022 and is expected to reach US$ 9.1 billion by 2030, growing with a CAGR of 7.4% during the forecast period 2023-2030.

Peripheral intravenous catheters (PIVCs) are the most commonly used intravenous devices which are primarily used for therapeutic purposes such as the administration of medications, fluids, and blood products. The catheter location, patency/occlusion, limb symmetry, any evidence of phlebitis (erythema, discomfort, swelling, pain, etc.), pressure injuries, and signs of infiltration/extravasation injuries are all evaluated in the assessment of peripheral IV Catheters.

Furthermore, the global peripheral IV catheter market is driven by a rise in the prevalence of chronic disorders, technological advancements, a rise in minimally invasive procedures, and strong healthcare expenditures that will drive the market during the forecast period.

Dynamics

Rise in the Prevalence of Cardiovascular Diseases

Patients with certain cardiovascular conditions, such as atrial fibrillation or deep vein thrombosis, may require anticoagulation treatment to avoid blood clots. Intravenous (IV) catheters can supply anticoagulant drugs like heparin to maintain healthy blood flow. The rise in the incidence of cardiovascular diseases is the significant key driver that drives the market during the forecast period.

For instance, according to the Centres for Disease Control and Prevention's updated factsheet 2023, heart disease is the main cause of death in the United States for men, women, and individuals of most racial and ethnic groups. In the United States, one person dies from cardiovascular disease every 33 seconds.

Approximately 695,000 persons in the United States died from heart disease in 2021, accounting for one out of every five fatalities. From 2018 to 2019, the United States spent around $239.9 billion on heart disease. This covers the expense of healthcare services, medications, and lost productivity as a result of mortality.

Rise in the Technological Advancements

Rise in the technological advancements is one of the key factors that drive the market during the forecast period. For instance, in April 2023, BD, a global medical technology company, launched the BD Prevue II System, an advanced ultrasound device with a specialized probe for optimal IV placement.

The system addresses the unmet need for IV access through real-time needle depth markers and features the BD Cue Needle Tracking System, providing high-quality ultrasound images of the needle trajectory. It is compatible with BD Cue Needle Tracking-enabled catheters. The BD Prevue II System is designed to provide clinicians with optimal IV placement and is easy to use.

Rise in the Geriatric Population

As the population ages, more medical procedures, such as intravenous therapy, are required. The need for peripheral IV catheters to provide medicine and fluids develops in tandem with the ageing population.

The elderly are more vulnerable to heart problems. The increased prevalence of age-related cardiac problems is predicted to increase demand for pacemakers as the global geriatric population grows.

For instance according to an article published by Clinical Cardiology Around 60% of the US population over the age of 60 have hypertension, leading to heart attacks which result in increased demand for peripheral iv catheters requirement. By 2060, the number of people aged 65 and over will reach 25% of the US population, with 20 Billion beyond the eighth decade.

Rising Needle-Stick Injuries Encouraging The Adoption of Peripheral Intravenous Catheters

For patients who require frequent injections, needle stick injuries from injection needles are a major problem. Handling, disassembling, or even disposal of needles and syringes can result in percutaneous wound injuries from needle tips. According to the America Medical Association Needle sticks are a common occurrence in the healthcare profession. It is estimated that 600 000 to 800 000 needlestick injuries occur per year in the United States.

For instance, In July 2022, B. Braun Medical Inc, a leader in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B. Braun for making IV access safer for the clinician by reducing the risk of needlestick injuries and exposure to blood

Risks and Complications Associated with the Catheters

Complications of PIVC in situ can arise, although they can be avoided with adequate aseptic procedures and device evaluation. Infection, phlebitis, catheter/fluid/medication presence, and difficulties with chronically unwell patients are all common consequences. When fluids or drugs are transported into surrounding tissue, infiltration/extravasation occurs; if this occurs, see the extravasation injury management nursing guideline. These issues can be avoided by employing proper aseptic techniques and evaluation.

Segment Analysis

The Global Peripheral IV Catheters market is segmented based on product, technology, end user and region.

The Integrated Peripheral Intravenous Catheters From The Product Segment Accounted for Approximately 42.5% of the Peripheral IV Catheters Share

The integrated peripheral intravenous catheters from the product segment with around 42.5% is expected to dominate during the forecast period. People adjusting the catheter to attach the extension set cause internal pressures in the vein to be reduced with integrated peripheral intravenous catheters. Following insertion, the use of integrated catheters offers additional fluid tubing connections or direct injections conducted via the dedicated port, which is somewhat upstream of the catheter itself and limits the movement of the catheter body against the internal vein wall.

For instance, according to research published in the British Journal of Nursing in August 2022, a close/integrated catheter reduces the danger of the healthcare professional coming into touch with the patient's blood and enables the safe collection of blood samples. It can assist prevent backflow into the cannula tip, minimising the risk of obstruction and the need for several insertions. It is also critical that the device stays stable after insertion to minimise micro-movements within the vessel (which might damage the tunica intima, resulting in mechanical phlebitis.

Geographical Penetration

North America Accounted for Approximately 39.6% of the Market Share

North America is estimated to hold about 39.6% of the total market share throughout the forecast period due to launches by the key players, rising chronic diseases and a growing senior population. Also, North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large market share of the region

For instance, in March 2022, Shockwave Medical, Inc, a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance. The Shockwave M5 + catheter, which has been in limited launch until today, is specifically designed to decrease IVL treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes.

Competitive Landscape

The major global players in the market include: Becton Dickinson, B. Braun Melsungen AG, Argon Medical, Vygon, ICU Medical Inc, VOGT Medical, RenovoRx Inc, Nipro Medical, Teleflex, Greiner Bio-One and among others.

COVID-19 Impact Analysis

Covid has a huge influence on the peripheral intravenous catheter market, which is facing substantial challenges The main issue is the difficulty to access raw materials required for the fabrication of peripheral intravenous catheters due to transportation facility issues. Furthermore, due to an increase in the number of patients suffering from COVID-19 and other life-threatening illnesses, product distributors are seeing unpredictable demand from retailers.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict had a moderate impact on the global peripheral IV catheters market, owing to the disruption of supply chains and the shortage of healthcare infrastructure where the impact directly hit on these factors. Overall, the impact of the import and export of devices is expected to have an influence on the overall global peripheral IV catheters market growth over the forecast period.

By Product

Integrated/Closed Peripheral Intravenous Catheters
Short Peripheral Intravenous Catheters
- Ported PIVC
- Non-Ported PIVC

Midline Catheters

By Technology

Conventional PIVC
Systems PIVC

By End User

Hospitals
Ambulatory Surgical Centers
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

In September 2022 B. B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced it has acquired the innovative Clik-FIX catheter securement device portfolio from Starboard Medical, Inc. B. Braun's acquisition builds on the company's history of product and program innovation to improve the patient experience and outcomes with peripheral intravenous (IV) therapy.
In May 2022, Access Vascular, Inc. (AVI) announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its HydroPICC Dual-Lumen catheter. Designed and constructed using the same proprietary hydrophilic biomaterial as AVI's single-lumen HydroPICC and HydroMID catheters, these devices showed a significant reduction in complications such as occlusions, replacements, Deep Vein Thrombosis and phlebitis in recent studies.

Why Purchase the Report?

To visualize the global Peripheral IV Catheters market segmentation based on product, technology, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of Peripheral IV Catheters market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global Peripheral IV Catheters market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Technology
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Prevalence of Cardiovascular Diseases
  - 4.1.1.2. Rise in the Technological Advancements
  - 4.1.1.3. Rise in the Geriatric Population
  - 4.1.1.4. Rising Needle-Stick Injuries Encouraging the Adoption of Peripheral Intravenous Catheters
- 4.1.2. Restraints
  - 4.1.2.1. Risks and Complications Associated with the Catheters
- 4.1.3. Opportunity
  - 4.1.3.1. Rise in the Minimal Invasive Procedures
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Integrated/Closed Peripheral Intravenous Catheters *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Short Peripheral Intravenous Catheters
7.4. Midline Catheters

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Conventional PIVC*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Systems PIVC

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Clinics

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Application
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Becton Dickinson*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. B. Braun Melsungen AG
12.3. Argon Medical
12.4. Vygon
12.5. ICU Medical, Inc
12.6. VOGT Medical
12.7. RenovoRx Inc
12.8. Nipro Medical
12.9. Teleflex
12.10. Griener Bio One

LIST NOT EXHAUSTIVE